Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Edwards Lifesciences Stock Quote

Edwards Lifesciences (NYSE: EW)

$89.20
(-1.2%)
-$1.08
Price as of April 15, 2024, 4:00 p.m. ET

Edwards Lifesciences Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
EW +5.74% +50.77% +8.56% +6,387%
S&P +22.34% +74.52% +11.78% +232%

Edwards Lifesciences Company Info

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

News & Analysis

The Fool has written over 100 articles on Edwards Lifesciences.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.